Lazard Asset Management
DBTX

Lazard Asset Management’s Decibel Therapeutics, Inc. Common Stock DBTX Stock Holding History

Lazard Asset Management’s Portfolio DBTX Stock Details DBTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-3,970
Closed -$15K – 2533
2023
Q2 		$15K Buy
+3,970
New +$14.6K ﹤0.01% 2161

Other funds holding DBTX

ACA
Atlas Capital Advisors Jackson, Wyoming $875M AUM

Lazard Asset Management's DBTX Position: Q3 2023 in Review

Lazard Asset Management sold out of Decibel Therapeutics, Inc. Common Stock (DBTX) in Q3 2023, closing a stake of 3,970 shares — an estimated $15K sold.

Lazard Asset Management first reported a position in DBTX in Q2 2023 and held it in 1 quarter. The position peaked at $15K in Q2 2023. 1 fund tracked by Wall St. Rank holds DBTX as of Q3 2023.

  • Lazard Asset Management reported no remaining Decibel Therapeutics, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • Lazard Asset Management sold 3,970 Decibel Therapeutics, Inc. Common Stock shares in Q3 2023, an estimated $15K.
  • Lazard Asset Management first reported a position in Decibel Therapeutics, Inc. Common Stock in Q2 2023 and held it in 1 quarter.
  • Lazard Asset Management's Decibel Therapeutics, Inc. Common Stock position peaked at $15K in Q2 2023.
  • 1 fund tracked by Wall St. Rank held Decibel Therapeutics, Inc. Common Stock as of Q3 2023.

Based on Lazard Asset Management's 13F filing for Q3 2023, filed 14 Nov 2023.